List of Tables
Table 1. Global Cancer Drug Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cancer Drug Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cancer Drug Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cancer Drug Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cancer Drug Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cancer Drug Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cancer Drug Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cancer Drug Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cancer Drug Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cancer Drug Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cancer Drug Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Cancer Drug Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cancer Drug Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Drug Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cancer Drug Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global Cancer Drug Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Cancer Drug Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global Cancer Drug Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Cancer Drug Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cancer Drug Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Cancer Drug Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cancer Drug Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Cancer Drug Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cancer Drug Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America Cancer Drug Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America Cancer Drug Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cancer Drug Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cancer Drug Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cancer Drug Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cancer Drug Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cancer Drug Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cancer Drug Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cancer Drug Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cancer Drug Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cancer Drug Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cancer Drug Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cancer Drug Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Drug Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cancer Drug Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cancer Drug Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cancer Drug Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Drug Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cancer Drug Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cancer Drug Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cancer Drug Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cancer Drug Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cancer Drug Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cancer Drug Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global Cancer Drug Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global Cancer Drug Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Cancer Drug Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Cancer Drug Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cancer Drug Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cancer Drug Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Cancer Drug Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Cancer Drug Therapy Price (USD/Unit) by Type (2020-2025)
Table 59. Global Cancer Drug Therapy Price (USD/Unit) by Type (2026-2031)
Table 60. Global Cancer Drug Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global Cancer Drug Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global Cancer Drug Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Cancer Drug Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Cancer Drug Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cancer Drug Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cancer Drug Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Cancer Drug Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Cancer Drug Therapy Price (USD/Unit) by Application (2020-2025)
Table 69. Global Cancer Drug Therapy Price (USD/Unit) by Application (2026-2031)
Table 70. Amgen / Allergan Company Information
Table 71. Amgen / Allergan Description and Business Overview
Table 72. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Amgen / Allergan Cancer Drug Therapy Product
Table 74. Amgen / Allergan Recent Developments/Updates
Table 75. Argos Therapeutics Company Information
Table 76. Argos Therapeutics Description and Business Overview
Table 77. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Argos Therapeutics Cancer Drug Therapy Product
Table 79. Argos Therapeutics Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca Cancer Drug Therapy Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Aveo Pharmaceuticals Company Information
Table 86. Aveo Pharmaceuticals Description and Business Overview
Table 87. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Aveo Pharmaceuticals Cancer Drug Therapy Product
Table 89. Aveo Pharmaceuticals Recent Developments/Updates
Table 90. Bayer Company Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Bayer Cancer Drug Therapy Product
Table 94. Bayer Recent Developments/Updates
Table 95. Exelixis Company Information
Table 96. Exelixis Description and Business Overview
Table 97. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Exelixis Cancer Drug Therapy Product
Table 99. Exelixis Recent Developments/Updates
Table 100. Incyte Company Information
Table 101. Incyte Description and Business Overview
Table 102. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Incyte Cancer Drug Therapy Product
Table 104. Incyte Recent Developments/Updates
Table 105. Merck Company Information
Table 106. Merck Description and Business Overview
Table 107. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Merck Cancer Drug Therapy Product
Table 109. Merck Recent Developments/Updates
Table 110. Roche Company Information
Table 111. Roche Description and Business Overview
Table 112. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Roche Cancer Drug Therapy Product
Table 114. Roche Recent Developments/Updates
Table 115. Bristol-Myers Squibb Company Information
Table 116. Bristol-Myers Squibb Description and Business Overview
Table 117. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bristol-Myers Squibb Cancer Drug Therapy Product
Table 119. Bristol-Myers Squibb Recent Developments/Updates
Table 120. Eisai Company Information
Table 121. Eisai Description and Business Overview
Table 122. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Eisai Cancer Drug Therapy Product
Table 124. Eisai Recent Developments/Updates
Table 125. Exelixis Company Information
Table 126. Exelixis Description and Business Overview
Table 127. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Exelixis Cancer Drug Therapy Product
Table 129. Exelixis Recent Developments/Updates
Table 130. Genentech (Roche) Company Information
Table 131. Genentech (Roche) Description and Business Overview
Table 132. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Genentech (Roche) Cancer Drug Therapy Product
Table 134. Genentech (Roche) Recent Developments/Updates
Table 135. Novartis Company Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Novartis Cancer Drug Therapy Product
Table 139. Novartis Recent Developments/Updates
Table 140. Pfizer Company Information
Table 141. Pfizer Description and Business Overview
Table 142. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Pfizer Cancer Drug Therapy Product
Table 144. Pfizer Recent Developments/Updates
Table 145. Prometheus Labs Company Information
Table 146. Prometheus Labs Description and Business Overview
Table 147. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Prometheus Labs Cancer Drug Therapy Product
Table 149. Prometheus Labs Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Cancer Drug Therapy Distributors List
Table 153. Cancer Drug Therapy Customers List
Table 154. Cancer Drug Therapy Market Trends
Table 155. Cancer Drug Therapy Market Drivers
Table 156. Cancer Drug Therapy Market Challenges
Table 157. Cancer Drug Therapy Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cancer Drug Therapy
Figure 2. Global Cancer Drug Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Drug Therapy Market Share by Type: 2024 & 2031
Figure 4. Targeted Therapy Product Picture
Figure 5. Chemotherapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Global Cancer Drug Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Cancer Drug Therapy Market Share by Application: 2024 & 2031
Figure 9. Angiogenesis Inhibitors
Figure 10. mTOR Inhibitors
Figure 11. Monoclonal Antibodies
Figure 12. Cytokine Immunotherapy (IL-2)
Figure 13. Global Cancer Drug Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cancer Drug Therapy Market Size (2020-2031) & (US$ Million)
Figure 15. Global Cancer Drug Therapy Sales (2020-2031) & (K Units)
Figure 16. Global Cancer Drug Therapy Average Price (USD/Unit) & (2020-2031)
Figure 17. Cancer Drug Therapy Report Years Considered
Figure 18. Cancer Drug Therapy Sales Share by Manufacturers in 2024
Figure 19. Global Cancer Drug Therapy Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Cancer Drug Therapy Players: Market Share by Revenue in Cancer Drug Therapy in 2024
Figure 21. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Cancer Drug Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Cancer Drug Therapy Sales Market Share by Country (2020-2031)
Figure 24. North America Cancer Drug Therapy Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Cancer Drug Therapy Sales Market Share by Country (2020-2031)
Figure 28. Europe Cancer Drug Therapy Revenue Market Share by Country (2020-2031)
Figure 29. Germany Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Cancer Drug Therapy Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Cancer Drug Therapy Revenue Market Share by Region (2020-2031)
Figure 36. China Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Cancer Drug Therapy Sales Market Share by Country (2020-2031)
Figure 47. Latin America Cancer Drug Therapy Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Cancer Drug Therapy Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Cancer Drug Therapy Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Cancer Drug Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Cancer Drug Therapy by Type (2020-2031)
Figure 57. Global Revenue Market Share of Cancer Drug Therapy by Type (2020-2031)
Figure 58. Global Cancer Drug Therapy Price (USD/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Cancer Drug Therapy by Application (2020-2031)
Figure 60. Global Revenue Market Share of Cancer Drug Therapy by Application (2020-2031)
Figure 61. Global Cancer Drug Therapy Price (USD/Unit) by Application (2020-2031)
Figure 62. Cancer Drug Therapy Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
